Monster Beverage has opened September with a painful disconnect — Street price targets cluster between $95 and $113, yet the stock closed Thursday at $43.82, down 6.5% on the week and 53% over the past month.
The most striking feature of this week's setup is the gap between where analysts think MNST should trade and where it actually trades. Following the August 6 earnings release — which sent the stock down 4.3% the next day and 51% over the subsequent five sessions — a cluster of firms raised their targets anyway. UBS lifted its target to $105. RBC Capital went to $100. Piper Sandler moved to $101. Evercore ISI pushed to $105. Every one of those changes was logged on August 7, the day after earnings. The consensus rating is Hold, with ten analysts sitting on that fence — no Buy-side stampede, but no mass downgrade wave either. The mean target implies roughly 130% upside from the current price. That gap is too large to be credible as a near-term guide; it more likely reflects targets set before the full severity of the post-earnings slide became clear, or analysts waiting for the next quarter to formally reset. Either way, the Street is not yet aligned with where the market is pricing this stock.
Short interest tells a quieter story this week than it did a week ago. SI edged down roughly 4% on the week to 3.7% of free float — still nearly double where it was a month ago, as noted in last week's note, but no longer accelerating. The borrow market remains wide open: availability is running above 6,900%, meaning lenders hold close to seventy times more shares than are currently borrowed. Cost to borrow is just 0.32%, actually down 14% on the week. The ORTEX short score has drifted lower over the past two weeks, from 38.7 to 37.3, consistent with a short position that built fast but is now consolidating rather than pressing higher. There is no squeeze dynamic here — this is a conviction short with unlimited room to add, not a crowded trade fighting for borrow.
Options positioning is the one signal that cuts against the bearish grain. The put/call ratio has dropped to 0.65, a 52-week low, well below its 20-day average of 0.77. That means call buyers are dominating the options tape at the very moment the stock is near recent lows — either a contrarian positioning play or hedged-seller activity keeping the ratio suppressed. It is not a clear bullish signal, but it does mean the options market is not piling into downside protection the way short sellers have been adding directional exposure. The two signals are pulling in opposite directions, and the divergence is worth watching.
Coca-Cola's position in the ownership register adds an unusual structural layer. The beverage giant holds roughly 21% of MNST and filed a Schedule 13D/A in January 2025 — an activist-classified disclosure, not a passive one. That stake creates a natural floor on certain corporate outcomes and aligns two of the largest names in global beverages. As always with 13D/G filings, the stake reflects the last disclosure and positions can shift without a follow-on filing once a holder moves below the 5% threshold. Peers have fared better this week: KDP rose 1.3%, while KO fell a more modest 1.8% — both pointing to sector-wide pressure being nowhere near the magnitude hitting Monster specifically.
The next scheduled catalyst is the Q3 earnings print on November 5. Between now and then, the key tension to track is whether analyst targets begin to migrate toward current price levels, or whether the stock rerates upward to close some of that $60-plus gap between market and consensus.
See the live data behind this article on ORTEX.
Open MNST on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
